IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:IVG - NL0015000LU4 - Common Stock
18.685 EUR
-0.03 (-0.16%)
We assign a fundamental rating of 4 out of 10 to IVG. IVG was compared to 109 industry peers in the Machinery industry. While IVG is still in line with the averages on profitability rating, there are concerns on its financial health. IVG is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year IVG was profitable.
In the past year IVG had a positive cash flow from operations.
IVG had positive earnings in 4 of the past 5 years.
IVG had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
IVG has a worse Return On Assets (1.73%) than 60.55% of its industry peers.
IVG has a Return On Equity of 12.39%. This is in the better half of the industry: IVG outperforms 74.31% of its industry peers.
IVG has a Return On Invested Capital of 4.53%. This is comparable to the rest of the industry: IVG outperforms 42.20% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IVG is below the industry average of 8.88%.
The last Return On Invested Capital (4.53%) for IVG is above the 3 year average (3.91%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROIC | 4.53% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
1.3 Margins
IVG has a Profit Margin of 2.17%. This is in the lower half of the industry: IVG underperforms 63.30% of its industry peers.
In the last couple of years the Profit Margin of IVG has grown nicely.
IVG has a Operating Margin (5.00%) which is in line with its industry peers.
IVG's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 16.49%, IVG is doing worse than 90.83% of the companies in the same industry.
IVG's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% |
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IVG is destroying value.
Compared to 1 year ago, IVG has less shares outstanding
Compared to 5 years ago, IVG has more shares outstanding
Compared to 1 year ago, IVG has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.77, we must say that IVG is in the distress zone and has some risk of bankruptcy.
IVG has a Altman-Z score (1.77) which is comparable to the rest of the industry.
IVG has a debt to FCF ratio of 14.82. This is a negative value and a sign of low solvency as IVG would need 14.82 years to pay back of all of its debts.
The Debt to FCF ratio of IVG (14.82) is worse than 70.64% of its industry peers.
IVG has a Debt/Equity ratio of 1.35. This is a high value indicating a heavy dependency on external financing.
IVG has a Debt to Equity ratio of 1.35. This is amonst the worse of the industry: IVG underperforms 82.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Altman-Z | 1.77 |
ROIC/WACC0.62
WACC7.31%
2.3 Liquidity
IVG has a Current Ratio of 1.98. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
IVG has a Current ratio of 1.98. This is in the better half of the industry: IVG outperforms 74.31% of its industry peers.
A Quick Ratio of 1.40 indicates that IVG should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.40, IVG is doing good in the industry, outperforming 77.98% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 |
3. Growth
3.1 Past
The earnings per share for IVG have decreased strongly by -23.43% in the last year.
The Earnings Per Share has been growing by 32.82% on average over the past years. This is a very strong growth
Looking at the last year, IVG shows a decrease in Revenue. The Revenue has decreased by -7.24% in the last year.
Measured over the past years, IVG shows a small growth in Revenue. The Revenue has been growing by 5.06% on average per year.
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%
3.2 Future
IVG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.81% yearly.
Based on estimates for the next years, IVG will show a small growth in Revenue. The Revenue will grow by 4.30% on average per year.
EPS Next Y-19.44%
EPS Next 2Y2.58%
EPS Next 3Y8.29%
EPS Next 5Y10.81%
Revenue Next Year-4.91%
Revenue Next 2Y1.21%
Revenue Next 3Y2.83%
Revenue Next 5Y4.3%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 13.94, which indicates a correct valuation of IVG.
82.57% of the companies in the same industry are more expensive than IVG, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of IVG to the average of the S&P500 Index (26.28), we can say IVG is valued slightly cheaper.
IVG is valuated reasonably with a Price/Forward Earnings ratio of 8.54.
Based on the Price/Forward Earnings ratio, IVG is valued cheaply inside the industry as 88.99% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.52, IVG is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.94 | ||
| Fwd PE | 8.54 |
4.2 Price Multiples
79.82% of the companies in the same industry are more expensive than IVG, based on the Enterprise Value to EBITDA ratio.
68.81% of the companies in the same industry are more expensive than IVG, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.67 | ||
| EV/EBITDA | 5.56 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.42
EPS Next 2Y2.58%
EPS Next 3Y8.29%
5. Dividend
5.1 Amount
IVG has a Yearly Dividend Yield of 1.77%.
IVG's Dividend Yield is a higher than the industry average which is at 2.37.
IVG's Dividend Yield is slightly below the S&P500 average, which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.77% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
27.33% of the earnings are spent on dividend by IVG. This is a low number and sustainable payout ratio.
DP27.33%
EPS Next 2Y2.58%
EPS Next 3Y8.29%
BIT:IVG (12/9/2025, 5:36:15 PM)
18.685
-0.03 (-0.16%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners37.12%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap5.07B
Revenue(TTM)14.48B
Net Income(TTM)322.00M
Analysts72.31
Price Target20.11 (7.63%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.77% |
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP27.33%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-15.44%
Max EPS beat(2)5.84%
EPS beat(4)3
Avg EPS beat(4)15.3%
Min EPS beat(4)-15.44%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)15.63%
EPS beat(12)8
Avg EPS beat(12)16.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-10.1%
Max Revenue beat(2)8.56%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-10.1%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.74%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.14%
PT rev (3m)0.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.3%
EPS NY rev (1m)-7.94%
EPS NY rev (3m)-9.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.67%
Revenue NY rev (1m)-2.64%
Revenue NY rev (3m)-2.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.94 | ||
| Fwd PE | 8.54 | ||
| P/S | 0.34 | ||
| P/FCF | 12.67 | ||
| P/OCF | 3.93 | ||
| P/B | 1.95 | ||
| P/tB | 9.18 | ||
| EV/EBITDA | 5.56 |
EPS(TTM)1.34
EY7.17%
EPS(NY)2.19
Fwd EY11.71%
FCF(TTM)1.47
FCFY7.89%
OCF(TTM)4.75
OCFY25.44%
SpS54.61
BVpS9.58
TBVpS2.04
PEG (NY)N/A
PEG (5Y)0.42
Graham Number17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROCE | 6% | ||
| ROIC | 4.53% | ||
| ROICexc | 5.79% | ||
| ROICexgc | 7.34% | ||
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% | ||
| FCFM | 2.7% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
ROICexc(3y)4.85%
ROICexc(5y)N/A
ROICexgc(3y)5.77%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexgc growth 3Y26.65%
ROICexgc growth 5Y12.05%
ROICexc growth 3Y25.45%
ROICexc growth 5Y11.07%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Debt/EBITDA | 2.37 | ||
| Cap/Depr | 119.97% | ||
| Cap/Sales | 6% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 86.98% | ||
| Profit Quality | 124.22% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 | ||
| Altman-Z | 1.77 |
F-Score6
WACC7.31%
ROIC/WACC0.62
Cap/Depr(3y)146.94%
Cap/Depr(5y)121.88%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.2%
Profit Quality(3y)212.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.43%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-61.54%
EPS Next Y-19.44%
EPS Next 2Y2.58%
EPS Next 3Y8.29%
EPS Next 5Y10.81%
Revenue 1Y (TTM)-7.24%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-9.61%
Revenue Next Year-4.91%
Revenue Next 2Y1.21%
Revenue Next 3Y2.83%
Revenue Next 5Y4.3%
EBIT growth 1Y-21.25%
EBIT growth 3Y38.23%
EBIT growth 5Y15.55%
EBIT Next Year67.57%
EBIT Next 3Y28.42%
EBIT Next 5YN/A
FCF growth 1Y-7.83%
FCF growth 3YN/A
FCF growth 5Y-8.52%
OCF growth 1Y-0.31%
OCF growth 3Y26.42%
OCF growth 5Y8.96%
IVECO GROUP NV / IVG.MI FAQ
Can you provide the ChartMill fundamental rating for IVECO GROUP NV?
ChartMill assigns a fundamental rating of 4 / 10 to IVG.MI.
Can you provide the valuation status for IVECO GROUP NV?
ChartMill assigns a valuation rating of 5 / 10 to IVECO GROUP NV (IVG.MI). This can be considered as Fairly Valued.
What is the profitability of IVG stock?
IVECO GROUP NV (IVG.MI) has a profitability rating of 5 / 10.
Can you provide the financial health for IVG stock?
The financial health rating of IVECO GROUP NV (IVG.MI) is 3 / 10.
What is the earnings growth outlook for IVECO GROUP NV?
The Earnings per Share (EPS) of IVECO GROUP NV (IVG.MI) is expected to decline by -19.44% in the next year.